Treatment Outcomes in Children with Stage III Non-Hodgkin's Lymphoma
Author Information
Author(s): C.R. Pinkerton, I. Hann, O.B. Eden, M. Gerrard, J. Berry, M.G. Mott
Primary Institution: United Kingdom Children's Cancer Study Group
Hypothesis
How much treatment is needed for children with stage III non-Hodgkin's lymphoma?
Conclusion
Most children with stage III disease limited to lymph nodes can be cured with a moderately intensive regimen, while those with multi-organ involvement likely require more intensive treatment.
Supporting Evidence
- Thirty-four children are alive relapse-free, suggesting a high cure rate.
- Fourteen patients (87%) who received the intensive MACHO regimen had extensive multi-organ disease.
- Six patients (21%) on the less intensive regimen relapsed.
Takeaway
Doctors are trying to figure out how much medicine kids with a certain type of cancer need to get better. Some kids can get better with less medicine, but others need more.
Methodology
Children aged 3 months to 16 years with stage III B cell non-Hodgkin's lymphoma were treated with either a standard or more intensive chemotherapy regimen.
Potential Biases
Allocation of patients to treatment regimens was based on disease extent, which may introduce bias.
Limitations
The study was not randomized, making it difficult to draw firm conclusions about treatment efficacy.
Participant Demographics
Children aged 3 months to 16 years, with a median age of 8 years.
Statistical Information
Confidence Interval
95% CI 57-90%
Want to read the original?
Access the complete publication on the publisher's website